Phathom Pharmaceuticals
(NASDAQ) PHAT
Phathom Pharmaceuticals Financials at a Glance
Market Cap
$893.58M
Revenue (TTM)
$175.11M
Net Income (TTM)
$221.25M
EPS (TTM)
$-3.05
P/E Ratio
-3.72
Dividend
$0.00
Beta (Volatility)
1.37 (Average)
Dividend
$0.00
Beta (Volatility)
1.37 (Average)
Price
$11.36
Volume
38,070
Open
$10.93
Price
$11.36
Volume
38,070
Open
$10.93
Previous Close
$11.36
Daily Range
$10.89 - $11.37
52-Week Range
$2.21 - $18.31
Dividend
$0.00
Beta (Volatility)
1.37 (Average)
Price
$11.36
Volume
38,070
Open
$10.93
Previous Close
$11.36
Daily Range
$10.89 - $11.37
52-Week Range
$2.21 - $18.31
PHAT News
PHAT: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Phathom Pharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareEmployees
371
CEO
Steven L. Basta, MBA
Website
www.phathompharma.comHeadquarters
Florham Park, NJ 07932, US
PHAT Financials
Key Financial Metrics (TTM)
Gross Margin
87%
Operating Margin
-91%
Net Income Margin
-1%
Return on Equity
0%
Return on Capital
-1%
Return on Assets
-85%
Earnings Yield
-26.88%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$893.58M
Shares Outstanding
78.80M
Volume
38.07K
Short Interest
0.00%
Avg. Volume
1.17M
Financials (TTM)
Gross Profit
$152.51M
Operating Income
$159.99M
EBITDA
$152.50M
Operating Cash Flow
$166.78M
Capital Expenditure
$229.00K
Free Cash Flow
$166.78M
Cash & ST Invst.
$129.97M
Total Debt
$2.71M
Phathom Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$57.58M
+94.1%
Gross Profit
$49.94M
+93.2%
Gross Margin
86.72%
N/A
Market Cap
$893.58M
N/A
Market Cap/Employee
$2.09M
N/A
Employees
427
N/A
Net Income
$21.15M
+71.6%
EBITDA
$98.79M
+277.5%
Quarterly Fundamentals
Net Cash
$127.26M
+149.4%
Accounts Receivable
$78.13M
+101.4%
Inventory
$5.52M
+72.0%
Long Term Debt
$2.06M
-99.6%
Short Term Debt
$648.00K
-96.8%
Return on Assets
-85.37%
N/A
Return on Invested Capital
-1.26%
N/A
Free Cash Flow
$4.89M
+92.3%
Operating Cash Flow
$5.00M
+92.1%